Page last updated: 2024-08-25

almagate and Macular Holes

almagate has been researched along with Macular Holes in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurihara, T; Nagai, N; Okamoto, T; Ozawa, Y; Shinoda, H; Tsubota, K1
Chang, LK; Chiang, A; Sarraf, D; Yu, F1
Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A1
Acquah, K; Day, S; Grossman, DS; Lee, PP; Mruthyunjaya, P; Sloan, FA1
Bird, A; Dietzel, M; Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Schumacher, M1
Bux, AV; Iaculli, C; Noci, ND; Querques, G1
Coco, RM; Fernández Muñoz, M; Hernandez, AG; Sanabria, MR1
Apte, RS; Blinder, KJ; Dhalla, MS; Hariprasad, SM; Tewari, A1
Sears, JE; Singh, RP1
Chang, LK; Flaxel, CJ; Lauer, AK; Sarraf, D1

Trials

1 trial(s) available for almagate and Macular Holes

ArticleYear
Retinal pigment epithelium tears in age-related macular degeneration treated with antiangiogenic drugs: a controlled study with long follow-up.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2012, Volume: 228, Issue:2

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Case-Control Studies; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Retinal Perforations; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity

2012

Other Studies

9 other study(ies) available for almagate and Macular Holes

ArticleYear
Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.
    BMC ophthalmology, 2014, Sep-30, Volume: 14

    Topics: Aged; Aptamers, Nucleotide; Basement Membrane; Coloring Agents; Epiretinal Membrane; Fluorescein Angiography; Humans; Indocyanine Green; Intraoperative Period; Male; Retinal Perforations; Vascular Endothelial Growth Factor A; Vitrectomy; Wet Macular Degeneration

2014
Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis.
    Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:9

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Macular Degeneration; Male; Predictive Value of Tests; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Pigment Epithelium; Retinal Vessels; Retrospective Studies; Risk Assessment; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A

2008
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
    Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:7

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage

2008
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.
    American journal of ophthalmology, 2011, Volume: 152, Issue:2

    Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Case-Control Studies; Endophthalmitis; Eye Diseases; Female; Follow-Up Studies; Health Services Research; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Male; Medicare Part B; Proportional Hazards Models; Ranibizumab; Retinal Detachment; Retinal Perforations; Retrospective Studies; United States; Uveitis; Vascular Endothelial Growth Factor A; Vitreous Hemorrhage

2011
Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Eye (London, England), 2011, Volume: 25, Issue:9

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Pigment Epithelium of Eye; Ranibizumab; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Vascular Endothelial Growth Factors; Visual Acuity

2011
Lamellar macular hole following intravitreal pegaptanib sodium (Macugen) injection for diabetic macular edema.
    International ophthalmology, 2011, Volume: 31, Issue:6

    Topics: Aged; Aptamers, Nucleotide; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Macular Edema; Retinal Perforations; Vascular Endothelial Growth Factor A

2011
Retinal pigment epithelial tear following intravitreal pegaptanib sodium.
    American journal of ophthalmology, 2006, Volume: 141, Issue:4

    Topics: Aged; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Pigment Epithelium of Eye; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Visual Acuity

2006
Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration.
    American journal of ophthalmology, 2006, Volume: 142, Issue:1

    Topics: Aged; Aptamers, Nucleotide; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Pigment Epithelium of Eye; Retinal Perforations; Rupture

2006
RPE tears after pegaptanib treatment in age-related macular degeneration.
    Retina (Philadelphia, Pa.), 2007, Volume: 27, Issue:7

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pigment Epithelium of Eye; Postoperative Complications; Retinal Perforations; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2007